Sarasota Doctors Hospital INC

Sarasota Doctors Hospital INC was paid $3.41M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is 99283, emergency room visit (moderate) — 41% of everything it billed.

33Billing provider infoSARASOTA DOCTORS HOSPITAL INC
SARASOTA, FL 34233

33aNPI1003862053assigned 05/25/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$3.41M

24GClaims147,716

24DCodes billed95

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#99 of 163

Median peer was paid$4.77M

This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	9,468	$145K
2019	29,994	$320K
2020	23,956	$287K
2021	34,570	$760K
2022	34,356	$1.08M
2023	12,744	$599K
2024incomplete	2,628	$227K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	41%	18,552	16,689	$1.41M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	15%	9,797	8,237	$524K
99282	Emergency department visit for the evaluation and management, low to moderate severity	7.0%	3,045	2,844	$237K
70450	Computed tomography, head or brain; without contrast material	4.9%	1,662	1,371	$169K
74177	Computed tomography, abdomen and pelvis; with contrast material	4.5%	1,332	1,159	$154K
99281	Emergency department visit for the evaluation and management, self-limited or minor	3.9%	1,369	1,252	$132K
74176	Computed tomography, abdomen and pelvis; without contrast material	3.8%	834	731	$130K
80053	Comprehensive metabolic panel	2.7%	7,638	6,189	$92K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.4%	1,311	1,079	$81K
80048	Basic metabolic panel (calcium, ionized)	1.3%	3,160	2,511	$44K
96361	Intravenous infusion, hydration; each additional hour	1.3%	491	438	$43K
A9270	Non-covered item or service	1.1%	4,377	1,374	$38K

83 more codes

87070		<1%	1,867	$31K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	596	$27K
71046	Radiologic examination, chest; 2 views	<1%	2,207	$26K
81001		<1%	4,774	$20K
85027		<1%	11,164	$19K
87400		<1%	3,111	$19K
71045	Radiologic examination, chest; single view	<1%	3,648	$18K
G0378	Hospital observation service, per hour	<1%	511	$13K
81003		<1%	2,374	$12K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	2,225	$10K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	4,476	$9K
82044		<1%	1,071	$9K
73630		<1%	318	$8K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,101	$8K
72125	Computed tomography, cervical spine; without contrast material	<1%	366	$8K
84484		<1%	2,739	$7K
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,202	$6K
J0690	Injection, cefazolin sodium, 500 mg	<1%	43	$6K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	5,868	$6K
81025		<1%	3,019	$6K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,981	$5K
73564		<1%	122	$5K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	337	$5K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	118	$5K
83735		<1%	2,126	$4K
73130		<1%	157	$3K
74018		<1%	43	$3K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	21	$3K
85610		<1%	1,923	$3K
87430		<1%	1,665	$3K
87077		<1%	570	$3K
87086	Culture, bacterial; quantitative colony count, urine	<1%	964	$3K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,991	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,010	$2K
84702		<1%	302	$2K
85730		<1%	885	$2K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	88	$2K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	314	$2K
83690		<1%	3,035	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	59	$2K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,504	$2K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	70	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	142	$2K
J7050	Infusion, normal saline solution, 250 cc	<1%	1,631	$1K
73610		<1%	114	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,665	$1K
87280		<1%	241	$1K
86900		<1%	384	$1K
87040		<1%	838	$1K
86901		<1%	385	$1K
87186		<1%	441	$1K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	2,568	$1K
73030		<1%	55	$1K
J3490	Unclassified drugs	<1%	199	$1K
82945		<1%	1,071	$940.10
73110		<1%	62	$930.35
80306		<1%	435	$753.19
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,192	$729.00
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	111	$586.38
84703		<1%	757	$573.40
87088		<1%	108	$390.86
12001		<1%	15	$349.68
96376		<1%	322	$211.89
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	42	$166.34
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	111	$153.96
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	217	$98.37
86850		<1%	96	$87.09
G1003	Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program	<1%	56	$70.97
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	794	$70.08
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	104	$59.78
83880		<1%	161	$56.02
85379		<1%	172	$52.34
J2704	Injection, propofol, 10 mg	<1%	14	$25.40
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	364	$10.54
84443	Thyroid stimulating hormone (TSH)	<1%	117	$7.68
83605		0%	648	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	261	$0.00
J2060	Injection, lorazepam, 2 mg	0%	151	$0.00
88305	Level IV - Surgical pathology, gross and microscopic examination	0%	20	$0.00
J2270	Injection, morphine sulfate, up to 10 mg	0%	1,060	$0.00
S0028	Injection, famotidine, 20 mg	0%	32	$0.00
93976		0%	14	$0.00
85007		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialENGLISH, BILL (CFO)